HomePER • ASX
add
Percheron Therapeutics Ltd
Previous close
$0.011
Day range
$0.010 - $0.010
Year range
$0.0050 - $0.14
Market cap
8.70M AUD
Avg Volume
8.24M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 75.89K | -87.35% |
Operating expense | 4.26M | 44.43% |
Net income | -4.27M | -79.96% |
Net profit margin | -5.62K | -1,322.84% |
Earnings per share | — | — |
EBITDA | -4.21M | -79.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.39M | 1.14% |
Total assets | 17.92M | -10.30% |
Total liabilities | 2.63M | -25.51% |
Total equity | 15.29M | — |
Shares outstanding | 1.09B | — |
Price to book | 1.10 | — |
Return on assets | -59.01% | — |
Return on capital | -68.83% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.27M | -79.96% |
Cash from operations | -4.23M | -78.43% |
Cash from investing | -3.62K | -10.09% |
Cash from financing | 7.00M | 27.50% |
Net change in cash | 2.76M | -11.31% |
Free cash flow | -2.42M | -71.87% |
About
CEO
Founded
2000
Headquarters
Website
Employees
8
